The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: Maintenance treatment

World Journal of Biological Psychiatry

Volumn 5, Issue 3, 2004, Pages 120-135

  Grunze, Heinz ^a   Kasper, Siegfried ^b   Goodwin, Guy ^c   Bowden, Charles ^d   Möller, Hans Jürgen ^a   Akiskal, Hagop ^e   Allain, Hervé ^e   Ayuso Gutiérrez, José ^e   Baldwin, David ^e   Bech, Per ^e   Benkert, Otto ^e   Berk, Michael ^e   Bitter, Istvan ^e   Bourgeois, Marc ^e   Burrows, Graham ^e   Calabrese, Joseph ^e   Cassano, Giovanni ^e   Cetkovich Bakmas, Marcelo ^e   Cookson, John C ^e   da Costa, Delcir ^e   George, Mihai ^e   Goodwin, Frank ^e   Heinze, Gerado ^e   Higuchi, Teruhiko ^e   Hirschfeld, Robert M ^e   Höschl, Cyril ^e   Holsboer Trachsler, Edith ^e   Jamison, Kay ^e   Katona, Cornelius ^e   Keller, Martin B ^e   Kulhara, Parmanand ^e   Kupfer, David J ^e   Lecrubier, Yves ^e   Leonard, Brian ^e   Licht, Rasmus W ^e   Lingjaerde, Odd ^e   Lublin, Henrik ^e   Maj, Mario ^e   Mendlewicz, Julien ^e   Mitchell, Philip ^e   Montgomery, Stuart ^e   Nemeroff, Charles ^e   Nolen, Willem ^e   Paykel, Eugene S ^e   Philipp, Michael ^e   Post, Robert ^e   Puzynski, Stanislaw ^e   Rihmer, Zoltan ^e   Rybakowski, Janusz K ^e   Vestergaard, Per ^e   Vieta, Eduard ^e   Walden, Jörg ^e   Whybrow, Peter C ^e   Yamada, Kazuo ^e   more..

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d Mays Cancer Center at UT Health San Antonio   (United States)

^e NONE

Author keywords

Antipsychotics; Bipolar disorder; Electroconvulsive therapy; Evidence based guidelines; Maintenance; Mood stabiliser; Pharmacotherapy; Prophylaxis

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CALCIUM ANTAGONIST; CARBAMAZEPINE; CLOZAPINE; HALOPERIDOL; IMIPRAMINE; LAMOTRIGINE; LITHIUM SALT; MILNACIPRAN; MOOD STABILIZER; NIMODIPINE; NORADRENALIN UPTAKE INHIBITOR; OLANZAPINE; OMEGA 3 FATTY ACID; OXCARBAZEPINE; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THYROID HORMONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE; CALCIUM CHANNEL BLOCKING AGENT; NEUROLEPTIC AGENT;

BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL TRIAL; DEPRESSION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG METABOLISM; DRUG WITHDRAWAL; EMBASE; EVIDENCE BASED MEDICINE; HUMAN; MAINTENANCE THERAPY; MEDLINE; META ANALYSIS; MONOTHERAPY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RAPID CYCLING BIPOLAR DISORDER; RELAPSE; REMISSION; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; CLASSIFICATION; DRUG COMBINATION; DRUG POTENTIATION; DRUG TOLERANCE; ELECTROCONVULSIVE THERAPY; HEALTH; INTERNATIONAL COOPERATION; MULTIMODALITY CANCER THERAPY; PERIODICITY; PSYCHIATRY; PSYCHOTHERAPY;

ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BIOLOGICAL PSYCHIATRY; BIPOLAR DISORDER; CALCIUM CHANNEL BLOCKERS; COMBINED MODALITY THERAPY; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; ELECTROCONVULSIVE THERAPY; HUMANS; INTERNATIONAL COOPERATION; PERIODICITY; PSYCHOTHERAPY; WORLD HEALTH;

EID: 16544379823     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970410029924     Document Type: Review

References (177)

1. Abou-Saleh, M and Coppen, A. (1986) Who responds to prophylactic lithium? J Affect Disord, 10, pp. 115-125.
2. Akiskal, H and Bourgeois, M and Angst, J and Post, R and Möller, H-J and Hirschfeld, R. (2000) Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders J Affect Disord, 59, pp. 5-30. Suppl 1
3. Altshuler, L and Post, R and Leverich, G and Mikalauskas, K and Rosoff, A and Ackerman, L. (1995) Antidepressant-induced mania and cycle acceleration: A controversy revisited Am J Psychiatry, 152, pp. 1130-1138.
4. Altshuler, L and Kiriakos, L and Calcagno, J and Goodman, R and Gitlin, M and Frye, M and Mintz, J. (2001) The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: A retrospective chart review J Clin Psychiatry, 62, pp. 612-616.
5. Altshuler, L and Suppes, T and Black, D and Nolen, W and Keck, P, Jr and Frye, M and McElroy, S and Kupka, R and Grunze, H and Walden, J and Leverich, G and Denicoff, K and Luckenbaugh, D and Post, R. (2003) Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up Am J Psychiatry, 160, pp. 1252-1262.
6. American, Psychiatric Association. (2002) American Psychiatric Association Practice Guidelines for the Treatment of Patients With Bipolar Disorder 2nd ed. Washington DC
7. Angst, J. (1981) Course of affective disorders. In Handbook of Biological Psychiatry. (pp. 225-242). New York: Marcel Dekker.
8. Angst, J. (1985) Switch from depression to mania-a record study over decades between 1920 and 1982 Psychopathology, 18, pp. 140-154.
9. Angst, J and Gamma, A. (2002) A new bipolar spectrum concept: A brief review Bipolar disorders, 4, pp. 11-14. Suppl 1
10. Angst, J and Preisig, M. (1995a) Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985 Schweiz Arch Neurol Psychiatr, 146, pp. 5-16.
11. Angst, J and Preisig, M. (1995b) Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985 Schweiz Arch Neurol Psychiatr, 146, pp. 17-23.
12. Baastrup, P and Schou, M. (1967) Lithium as a prophylactic agent. Its effect against recurrent depressions and manic-depressive psychosis Arch Gen Psychiatry, 16, pp. 162-172.
13. Baldessarini, R and Tondo, L and Hennen, J. (1999a) Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders J Clin Psychiatry, 60, pp. 77-84.
14. Baldessarini, R and Tondo, L and Hennen, J and Floris, G. (1999b) Latency and episodes before treatment: Response to lithium maintenance in bipolar I and II disorders Bipolar Disord, 1, pp. 91-97.
15. Baldessarini, R and Tondo, L and Viguera, A. (1999c) Discontinuing lithium maintenance treatment in bipolar disorders: Risks and implications Bipolar Disord, 1, pp. 17-24.
16. Banov, M and Zarate, C, Jr and Tohen, M and Scialabba, D and Wines, J, Jr and Kolbrener, M and Kim, J and Cole, J. (1994) Clozapine therapy in refractory affective disorders: Polarity predicts response in longterm follow-up J Clin Psychiatry, 55, pp. 295-300.
17. Bauer, M and Whybrow, P. (1990) Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: A preliminary study Arch Gen Psychiatry, 47, pp. 435-440.
18. Begley, C and Annegers, J and Swann, A and Lewis, C and Coan, S and Schnapp, W and Bryant-Comstock, L. (2001) The lifetime cost of bipolar disorder in the US: An estimate for new cases in 1998 Pharmacoeconomics, 19, pp. 483-495.
19. Benazzi, F. (1997) Antidepressant-associated hypomania in outpatient depression: A 203-case study in private practice J Affect Disord, 46, pp. 73-77.
20. Benazzi, F. (2001) Prevalence and clinical correlates of residual depressive symptoms in bipolar II disorder Psychother Psychosom, 70, pp. 232-238.
21. Bocchetta, A and Chillotti, C and Severino, G and Ardau, R and Del Zompo, M. (1997) Carbamazepine augmentation in lithium-refractory bipolar patients: A prospective study on long-term prophlyactic effectiveness J Clin Psychopharmacol, 17, pp. 92-96.
22. Bowden, C and Calabrese, J and McElroy, S and Rhodes, L and Keck, P and Cookson, J and Anderson, J and Bolden-Watson, C and Ascher, J and Monaghan, E and Zhou, J. (1999) The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder Biol Psychiatry, 45, pp. 953-958.
23. Bowden, C and Calabrese, J and McElroy, S and Gyulai, L and Wassef, A and Petty, F and Pope, H and Chou, J and Keck, P and Rhodes, L and Swann, A and Hirschfeld, R and Wozniak, P. (2000a) A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder, Divalproex Maintenance Study Group Arch Gen Psychiatry, 57, pp. 481-489.
24. Bowden, C and Lecrubier, Y and Bauer, M and Goodwin, G and Greil, W and Sachs, G and von Knorring, L. (2000b) Maintenance therapies for classic and other forms of bipolar disorder J Affect Disord, 59, pp. 57-67. Suppl 1
25. Bowden, C and Calabrese, J and Sachs, G and Yatham, L and Asghar, S and Hompland, M and Montgomery, P and Earl, N and Smoot, T and DeVeaugh-Geiss, J. (2003) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder Arch Gen Psychiatry, 60, pp. 392-400.
26. Burgess, S and Geddes, J and Hawton, K and Townsend, E and Jamison, K and Goodwin, G. (2001) Lithium for maintenance treatment of mood disorders Cochrane Database Syst RevCD003013.
27. Calabrese, J and Delucchi, G. (1990) Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder Am J Psychiatry, 147, pp. 431-434.
28. Calabrese, J and Meltzer, H and Markovitz, P. (1991) Clozapine prophylaxis in rapid cycling bipolar disorder J Clin Psychopharmacol, 11, pp. 396-397.
29. Calabrese, J and Rapport, D and Kimmel, S and Reece, B and Woyshville, M. (1993) Rapid cycling bipolar disorder and its treatment with valproate Can J Psychiatry, 38, pp. 57-61.
30. Calabrese, J and Rapport, D and Shelton, M and Kimmel, S. (1998) Clinical studies on the use of lamotrigine in bipolar disorder Neuropsychobiology, 38, pp. 185-191.
31. Calabrese, J and Bowden, C and McElroy, S and Cookson, J and Andersen, J and Keck, P and Rhodes, L and Bolden-Watson, C and Zhou, J and Ascher, J. (1999a) Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder Am J Psychiatry, 156, pp. 1019-1023.
32. Calabrese, J and Bowden, C and Sachs, G and Ascher, J and Monaghan, E and Rudd, G. (1999b) A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression J Clin Psychiatry, 60, pp. 79-88. for the Lamictal 602 Study Group
33. Calabrese, J and Shelton, M and Rapport, D and Kimmel, S. (2002) Bipolar disorders and the effectiveness of novel anticonvulsants J Clin Psychiatry, 63, pp. 5-9. Suppl 3
34. Calabrese, J and Bowden, C and Sachs, G and Yatham, L and Behnke, K and Mehtonen, O-P and Montgomery, P and Ascher, J and Paska, W and Earl, N and DeVeaugh-Geiss, J. (2003a) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder J Clin Psychiatry, 64, pp. 1024. for the Lamictal 605 Study group
35. Calabrese, J and Shelton, M and Rapport, D and Youngstrom, E and Shirley, E and Elhaj, O and Packer, K and Bilali, S and Findling, R. (2003b) A 20-month, double-blind, maintenance study of lithium versus divalproex monotherapy in bipolar I and II disorder accompanied by rapid cycling Eur Neuropsychopharmacol, 23, pp. 227. Suppl 4
36. Calabrese, J and Kasper, S and Johnson, G and Tajima, O and Vieta, E and Yatham, L and Young, A. (2004) International Consensus Group on Bipolar I Depression Treatment Guidelines J Clin Psychiatry, 65, pp. 571-579.
37. Ciapparelli, A and Dell'Osso, L and Pini, S and Chiavacci, M and Fenzi, M and Cassano, G. (2000) Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24month naturalistic study J Clin Psychiatry, 61, pp. 329-334.
38. Colom, F and Vieta, E and Martinez-Aran, A and Reinares, M and Goikolea, J and Benabarre, A and Torrent, C and Comes, M and Corbella, B and Parramon, G and Corominas, J. (2003) A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission Arch Gen Psychiatry, 60, pp. 402-407.
39. Coppen, A and Chaundry, S and Swade, C. (1986) Folic acid enhances lithium prophylaxis J Affect Disord, 10, pp. 9-13.
40. Coryell, W and Scheftner, W and Keller, M and Endicott, J and Maser, J and Klerman, G. (1993) The enduring psychosocial consequences of mania and depression Am J Psychiatry, 150, pp. 720-727.
41. Csernansky, J and Mahmoud, R and Brenner, R. (2002) A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia N Engl J Med, 346, pp. 16-22.
42. Dardennes, R and Even, C and Bange, F and Heim, A. (1995) Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders. A meta-analysis Br J Psychiatry, 166, pp. 378-381.
43. Denicoff, K and Smith-Jackson, E and Bryan, A and Ali, S and Post, R. (1997a) Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder Am J Psychiatry, 154, pp. 1456-1458.
44. Denicoff, K and Smith-Jackson, E and Disney, E and Ali, S and Leverich, G and Post, R. (1997b) Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder J Clin Psychiatry, 58, pp. 470-478.
45. Di Costanzo, E and Schifano, F. (1991) Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder Acta Psychiatr Scand, 83, pp. 456-459.
46. Dickson, W and Kendell, R. (1986) Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions? Psychol Med, 16, pp. 521-530.
47. Dunner, D and Fieve, R. (1974) Clinical factors in lithium carbonate prophylaxis failure Arch Gen Psychiatry, 30, pp. 229-233.
48. Dunner, D and Stallone, F and Fieve, R. (1976) Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness Arch Gen Psychiatry, 33, pp. 117-120.
49. Emrich, H and Wolf, R. (1992) Valproate treatment of mania Prog Neuropsychopharmacol Biol Psychiatry, 16, pp. 691-701.
50. Fatemi, S and Rapport, D and Calabrese, J and Thuras, P. (1997) Lamotrigine in rapid-cycling bipolar disorder J Clin Psychiatry, 58, pp. 522-527.
51. Fieve, R and Kumbaraci, T and Dunner, D. (1976) Lithium prophylaxis of depression in bipolar I. bipolar II. and unipolar patients Am J Psychiatry, 133, pp. 925-929.
52. Franchini, L and Zanardi, R and Smeraldi, E and Gasperini, M. (1999) Early onset of lithium prophylaxis as a predictor of good long-term outcome Eur Arch Psychiatry Clin Neurosci, 249, pp. 227-230.
53. Frye, M and Altshuler, L and Bitran, J. (1996) Clozapine in rapid cycling bipolar disorder J Clin Psychopharmacol, 16, pp. 87-90.
54. Frye, M and Ketter, T and Leverich, G and Huggins, T and Lantz, C and Denicoff, K and Post, R. (2000) The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study J Clin Psychiatry, 61, pp. 9-15.
55. Garcia-Lopez, A and Ezquiaga, E and Nieves, P and Rodriguez-Salvanes, F. (2001) Factores predictores de respuesta al litio en pacientes bipolares en seguimiento a largo plazo Actas Esp Psiquiatr, 29, pp. 327-332.
56. Geddes, J and Burgess, S and Hawton, K and Jamison, K and Goodwin, G. (2004) Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials Am J Psychiatry, 161, pp. 217-222.
57. Gelenberg, A and Kane, J and Keller, M and Lavori, P and Rosenbaum, J and Cole, K and Lavelle, J. (1989) Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder N Engl J Med, 321, pp. 1489-1493.
58. Ghaemi, S and Goodwin, F. (1999) Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: Review of the empirical literature J Clin Psychopharmacol, 19, pp. 354-361.
59. Ghaemi, S and Boiman, E and Goodwin, F. (2000) Diagnosing bipolar disorder and the effect of antidepressants: A naturalistic study J Clin Psychiatry, 61, pp. 804-808.
60. Ghaemi, S and Lenox, M and Baldessarini, R. (2001) Effectiveness and safety of long-term antidepressant treatment in bipolar disorder J Clin Psychiatry, 62, pp. 565-569.
61. Goldberg, J and Harrow, M and Leon, A. (1996) Lithium treatment of bipolar affective disorders under naturalistic followup conditions Psychopharmacol Bull, 32, pp. 47-54.
62. Goodwin, F. (2002) Rationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment J Clin Psychiatry, 63, pp. 5-12. Suppl 10
63. Goodwin, F and Fireman, B and Simon, G and Hunkeler, E and Lee, J and Revicki, D. (2003) Suicide risk in bipolar disorder during treatment with lithium and divalproex 1 JAMA, 290, pp. 1467-1473.
64. Goodwin, G. (1994) Recurrence of mania after lithium withdrawal, Implications for the use of lithium in the treatment of bipolar affective disorder Br J Psychiatry, 164, pp. 149-152.
65. Goodwin, G. (2003) Evidence-based guidelines for treating bipolar disorder: Recommendations from the British Association for Psychopharmacology J Psychopharmacol, 17, pp. 149-173.
66. Goodwin, G and Bowden, C and Calabrese, J and Grunze, H and Kasper, S and White, R and Greene, P and Leadbetter, R. (2004) A meta-analysis of two placebo-controlled 18-month trials of lamotrigine and lithium maintenance in Bipolar I disorder J Clin Psychiatry, 65, pp. 432-441. J and Grunze, H and Kasper, S and White, R and Greene, P and Leadbetter, R. (2004) A meta-analysis of two placebo-controlled 18-month trials of lamotrigine and lithium maintenance in Bipolar I disorder J Clin Psychiatry, 65, pp. 432-441.
67. Greil, W and Kleindienst, N. (1999) Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified Int Clin Psychopharmacol, 14, pp. 283-285.
68. Greil, W and Ludwig-Mayerhofer, W and Erazo, N and Engel, R and Czernik, A and Giedke, H and Müller-Oerlinghausen, B and Osterheider, M and Rudolf, G and Sauer, H and Tegeler, J and Wetterling, T. (1997a) Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: A randomised study Eur Arch Psychiatry Clin Neurosci, 247, pp. 42-50.
69. Greil, W and Ludwig-Mayerhofer, W and Erazo, N and Schöchlin, C and Schmidt, S and Engel, R and Czernik, A and Giedke, H and Müller-Oerlinghausen, B and Osterheider, M and Rudolf, G and Sauer, H and Tegeler, J and Wetterling, T. (1997b) Lithium versus carbamazepine in the maintenance treatment of bipolar disorders-a randomised study J Affect Disord, 43, pp. 151-161.
70. Greil, W and Kleindienst, N and Erazo, N and Müller-Oerlinghausen, B. (1998) Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder J Clin Psychopharmacol, 18, pp. 455-460.
71. Grunze, H and Walden, J. (2002) Relevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorder J Affect Disord, 72, pp. 15-21. Suppl 1
72. Grunze, H and Kasper, S and Goodwin, G and Bowden, C and Baldwin, D and Licht, R and Vieta, E and Möller, H-J and WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. (2002a) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders. Part I: Treatment of Bipolar Depression World J Biol Psychiatry, 3, pp. 115-124.
73. Grunze, H and Kasper, S and Goodwin, G and Bowden, C and Baldwin, D and Licht, R and Vieta, E and Möller, H-J and WFSBP, Task Force on Treatment Guidelines for Bipolar Disorders. (2003) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders. Part II: Treatment of Mania World J Biol Psychiatry, 4, pp. 5-13.
74. Grunze, H and Walden, J and Dittmann, S and Berger, M and Bergmann, A and Bräunig, P and Dose, M and Emrich, H and Gastpar, M and Greil, W and Möller, H-J and Uebelhack, R. (2002b) Psychopharmakotherapie Bipolarer Affektiver Erkrankungen Nervenarzt, 73, pp. 4-17.
75. Gupta, S and Austin, R and Devanand, D. (1998) Lithium and maintenance electroconvulsive therapy J ECT, 14, pp. 241-244.
76. Harrow, M and Goldberg, J and Grossman, L and Meltzer, H. (1990) Outcome in manic disorders, A naturalistic follow-up study Arch Gen Psychiatry, 47, pp. 665-671.
77. Hartong, E and Moleman, P and Hoogduin, C and Broekman, T and Nolen, W. (2003) Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients J Clin Psychiatry, 64, pp. 144-151.
78. Hayes, S. (1989) Long-term use of valproate in primary psychiatric disorders J Clin Psychiatry, 50. (Suppl), 35-39
79. Hesslinger, B and Normann, C and Langosch, J and Klose, P and Berger, M and Walden, J. (1999) Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients J Clin Psychopharmacol, 19, pp. 310-315.
80. Hirschfeld, R and Weisler, R and Keck, P. (1999). Cost-effectiveness evaluation of divalproex versus lithium in the treatment of bipolar disorder. 152nd APA Annual meeting abstracts NR 686.
81. Hummel, B and Dittmann, S and Forsthoff, A and Matzner, N and Amann, B and Grunze, H. (2002) Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders: A case series Neuropsychobiology, 45, pp. 37-42. Suppl 1
82. Jacobsen, F. (1993) Low-dose valproate: A new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome J Clin Psychiatry, 54, pp. 229-234.
83. Johnson, R and McFarland, B. (1996) Lithium use and discontinuation in a health maintenance organization Am J Psychiatry, 153, pp. 993-1000.
84. Joyce, P. (1988) Carbamazepine in rapid cycling bipolar affective disorder Int Clin Psychopharmacol, 3, pp. 123-129.
85. Judd, L and Akiskal, H and Schettler, P and Coryell, W and Maser, J and Rice, J and Solomon, D and Keller, M. (2003) The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? J Affect Disord, 73, pp. 19-32.
86. Kane, J and Quitkin, F and Rifkin, A and Ramos-Lorenzi, J and Nayak, D and Howard, A. (1982) Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: A prospective, placebo-controlled comparison Arch Gen Psychiatry, 39, pp. 1065-1069.
87. Kasper, S and Stamenkovic, M and Letmaier, M and Schreinzer, D. (2002) Atypical antipsychotics in mood disorders Int Clin Psychopharmacol, 17, pp. 1-10. Suppl 3
88. Kasper, S and Tauscher, J and Aschauer, H and Danzinger, R and Friedl, E and Friedrich, M and Haring, C and Kalousek, M and Kapfhammer, H and König, P and Lehofer, M and Platz, T and Schubert, H and Simhandl, C and Stuppäck, C and Tauscher-Wisniewski, S and Windhager, E and Wolf, W. (2003) Bipolare Störungen. Medikamentöse Therapie, Konsensus-Statement - State of the Art 2003 CliniCum psy Sonderausgabe.
89. Keck, P and McElroy, S. (1996) Outcome in the pharmacologic treatment of bipolar disorder J Clin Psychopharmacol, 16, pp. 15S-23S.
90. Keck, P and McElroy, S and Strakowski, S. (1996) New developments in the pharmacologic treatment of schizoaffective disorder J Clin Psychiatry, 57, pp. 41-48. Suppl 9
91. Kessing. (1998) Recurrence in affective disorders British J Psychiatry, 172, pp. 23-28.
92. Ketter, T and Calabrese, J. (2002) Stabilization of mood from below versus above baseline in bipolar disorder: A new nomenclature J Clin Psychiatry, 63, pp. 146-151.
93. Kraepelin E.Manisch-depressives Irresein und Paranoia, 1921.
94. Kramer, B. (1999) A naturalistic review of maintenance ECT at a university setting J ECT, 15, pp. 262-269.
95. Kupka, R and Luckenbaugh, D and Post, R and Leverich, G and Nolen, W. (2003) Rapid and non-rapid cycling bipolar disorder: A metaanalysis of clinical studies J Clin Psychiatry, 64, pp. 1483-1494.
96. Kupka, R and Luckenbaugh, D and Post, R and Altshuler, L and Denicoff, K and Frye, M and Grunze, H and Keck, P and Leverich, G and McElroy, S and Suppes, T and Walden, J and Nolen, W. (2004) A comparative study of rapid and non-rapid cycling bipolar disorder using daily prospective mood ratings in 539 outpatients Am.J Psychiatry. In press
97. Kurz, M and Hummer, M and Kemmler, G and Kurzthaler, I and Saria, A and Fleischhacker, W. (1998) Long-term pharmacokinetics of clozapine Br J Psychiatry, 173, pp. 341-344.
98. Kusumakar, V and Yatham, L. (1997) Lamotrigine treatment of rapid cycling bipolar disorder Am J Psychiatry, 154, pp. 1171-1172.
99. Lambert, P. (1984) Acute and prophylactic therapies of patients with affective disorders using valpromide(dipropylacetamide). In Anticonvulsants in affective disorders. (pp. 33-44). Amsterdam: Elsevier Science Publishers. Oxford, Princeton
100. Lehman, A and Steinwachs, D. (1998) Translating research into practice: the Schizophrenia Patient Outcomes Research Team(PORT) treatment recommendations Schizophr Bull, 24, pp. 1-10.
101. Lenz, G and Wolf, R and Simhandl, C and Topitze, A and Berner, P. (1989) Langzeitprognose und Rückfallprophylaxe der schizoaffektiven Psychosen. In Schizoaffektive Psychosen: Diagnose, Therapie und Prophylaxe. (pp. 55-66). Berlin: Springer.
102. Licht, R and Gouliaev, G and Vestergaard, P and Frydenberg, M. (1997) Generalisability of results from randomised drug trials, A trial on antimanic treatment Br J Psychiatry, 170, pp. 264-267.
103. Licht, R and Vestergaard, P and Kessing, L and Larsen, J and Thomsen, P. (2003) Psychopharmacological treatment with lithium and antiepileptic drugs: Suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark Acta Psychiatr Scand Suppl, pp. 1-22.
104. Littlejohn, R and Leslie, F and Cookson, J. (1994) Depot antipsychotics in the prophylaxis of bipolar affective disorder Br J Psychiatry, 165, pp. 827-829.
105. Lusznat, R and Murphy, D and Nunn, C. (1988) Carbamazepine vs lithium in the treatment and prophylaxis of mania Br J Psychiatry, 153, pp. 198-204.
106. Macritchie, K and Geddes, J and Scott, J and Haslam, D and Goodwin, G. (2001) Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder Cochrane Database Syst RevCD003196.
107. Maj, M. (1992) Clinical prediction of response to lithium prophylaxis in bipolar patients: A critical update Lithium, 3, pp. 15-21.
108. Maj, M and Pirozzi, R and Kemali, D. (1991) Long-term outcome of lithium prophylaxis in bipolar patients Arch Gen Psychiatry, 48, pp. 772.
109. Maj, M and Pirozzi, R and Magliano, L and Bartoli, L. (1998) Long-term outcome of lithium prophylaxis in bipolar disorder: A 5-year prospective study of 402 patients at a lithium clinic Am J Psychiatry, 155, pp. 30-35.
110. Maj, M and Pirozzi, R and Formicola, A and Bartoli, L and Bucci, P. (2000) Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: Preliminary data J Affect Disord, 57, pp. 95-98.
111. Mander, A and Loudon, J. (1988) Rapid recurrence of mania following abrupt discontinuation of lithium Lancet, 2, pp. 15-17.
112. Margolese, H and Chouinard, G and Beauclair, L and Belanger, M. (2002) Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder J Clin Psychopharmacol, 22, pp. 347-352.
113. Marneros A. (2001) Expanding the group of bipolar disorders J Affect Disord, 62, pp. 39-44.
114. McElroy, S and Keck, P. (1993) Treatment guidelines for valproate in bipolar and schizoaffective disorders Can J Psychiatry, 38, pp. 62-66.
115. Mukherjee, S and Rosen, A and Caracci, G and Shukla, S. (1986) Persistent tardive dyskinesia in bipolar patients Arch Gen Psychiatry, 43, pp. 342-346.
116. Müller-Oerlinghausen, B and Thies, K and Volk, J. (1989) Lithium in der Prophylaxe schizoaffektiver Psychosen, Erste Ergebnissse der Berliner Lithium- Katamnese. In Schizoaffektive Psychosen: Diagnose, Therapie und Prophylaxe. (pp. 191-195). Berlin: Springer.
117. Müller-Oerlinghausen, B and Berghofer, A and Bauer, M. (2002) Bipolar disorder Lancet, 359, pp. 241-247.
118. Nolen, W and Knoppert-van der Klein, E and Bouvy, P and Honig, A and Klompenhouwer, J and De Wit, A and Ravelli, D. (2001) Richtlijn bipolaire stoornissen. Amsterdam: Boom.
119. Okuma, T. (1993) Effects of carbamazepine and lithium on affective disorders Neuropsychobiology, 27, pp. 138-145.
120. Okuma, T and Inanaga, K and Otsuki, S and Sarai, K and Takahashi, R and Hazama, H and Mori, A and Watanabe, S. (1981) A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness Psychopharmacology Berl, 73, pp. 95-96.
121. Pazzaglia, P and Post, R and Ketter, T and George, M and Marangell, L. (1993) Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation Psychiatry Res, 49, pp. 257-272.
122. Pazzaglia, P and Post, R and Ketter, T and Callahan, A and Marangell, L and Frye, M and George, M and Kimbrell, T and Leverich, G and Cora-Locatelli, G and Luckenbaugh, D. (1998) Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness J Clin Psychopharmacol, 18, pp. 404-413.
123. Peselow, E and Dunner, D and Fieve, R and Lautin, A. (1982) Lithium prophylaxis of depression in unipolar, bipolar II, and cyclothymic patients Am J Psychiatry, 139, pp. 747-752.
124. Placidi, G and Lenzi, A and Lazzerini, F and Cassano, G and Akiskal, H. (1986) The comparative efficacy and safety of carbamazepine versus lithium: A randomized, double-blind 3-year trial in 83 patients J Clin Psychiatry, 47, pp. 490-494.
125. Post, R and Kramlinger, K and Altshuler, L and Ketter, T and Denicoff, K. (1990) Treatment of rapid cycling bipolar illness Psychopharmacol Bull, 26, pp. 37-47.
126. Post, R and Leverich, G and Altshuler, L and Mikalauskas, K. (1992) Lithium-discontinuation-induced refractoriness: Preliminary observations Am J Psychiatry, 149, pp. 1727-1729.
127. Post, R and Ketter, T and Pazzaglia, P and Denicoff, K and George, M and Callahan, A and Leverich, G and Frye, M. (1996) Rational polypharmacy in the bipolar affective disorders Epilepsy Res 11 Suppl, pp. 153-180. 153-180.
128. Prien, R and Caffey, E and Klett, C. (1973a) Prophylactic efficacy of lithium carbonate in manic-depressive illness, Report of the Veterans Administration and National Institute of Mental Health collaborative study group Arch Gen Psychiatry, 28, pp. 337-341.
129. Prien, R and Klett, C and Caffey, E. (1973b) Lithium carbonate and imipramine in prevention of affective episodes, A comparison in recurrent affective illness Arch Gen Psychiatry, 29, pp. 420-425.
130. Prien, R and Kupfer, D and Mansky, P and Small, J and Tuason, V and Voss, C and Johnson, W. (1984) Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders, Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination Arch Gen Psychiatry, 41, pp. 1096-1104.
131. Puri, B and Taylor, D and Alcock, M. (1995) Low-dose maintenance clozapine treatment in the prophylaxis of bipolar affective disorder Br J Clin Pract, 49, pp. 333-334.
132. Puzynski, S and Klosiewicz, L. (1984) Valproic acid amide in the treatment of affective and schizoaffective disorders J Affect Disord, 6, pp. 115-121.
133. Rabheru, K and Persad, E. (1997) A review of continuation and maintenance electroconvulsive therapy Can J Psychiatry, 42, pp. 476-484.
134. Rihmer, Z and Pestality, P. (1999) Bipolar II disorder and suicidal behavior Psychiatr Clin North Am, 22, pp. 667-673.
135. Roy-Byrne, P and Post, R and Uhde, T and Porcu, T and Davis, D. (1985) The longitudinal course of recurrent affective illness: Life chart data from research patients at the NIMH Acta Psychiatr Scand Suppl, 317, pp. 1-34.
136. Royal Australian New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder. (2004) Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder Aust N Z J Psychiatry, 38, pp. 280-305.
137. Rush, A and Rago, W and Crismon, M and Toprac, M and Shon, S and Suppes, T and Miller, A and Trivedi, M and Swann, A and Biggs, M and Shores-Wilson, K and Kashner, T and Pigott, T and Chiles, J and Gilbert, D and Altshuler, K. (1999) Medication treatment for the severely and persistently mentally ill: The Texas Medication Algorithm Project J Clin Psychiatry, 60, pp. 284-291.
138. Sachs, G and Printz, D and Kahn, D and Carpenter, D and Docherty, J. (2000) The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000 Postgrad Med Spec Report, pp. 1-104.
139. Scott, J. (2002) Using health belief models to understand the efficacy-effectiveness gap for mood stabilizer treatments Neuropsychobiology. In press
140. Severus, W and Ahrens, B and Stoll, A. (1999) Omega-3 fatty acids-the missing link? Arch Gen Psychiatry, 56, pp. 380-381.
141. Shapiro, D and Quitkin, F and Fleiss, J. (1989) Response to maintenance therapy in bipolar illness, Effect of index episode Arch Gen Psychiatry, 46, pp. 401-405.
142. Sharma, V and Persad, E and Mazmanian, D and Karunaratne, K. (1993) Treatment of rapid cycling bipolar disorder with combination therapy of valproate and lithium Can J Psychiatry, 38, pp. 137-139.
143. Solomon, D and Ryan, C and Keitner, G and Miller, I and Shea, M and Kazim, A and Keller, M. (1997) A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder J Clin Psychiatry, 58, pp. 95-99.
144. Solomon, D and Keitner, G and Ryan, C and Miller, I. (1998) Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: A review J Clin Psychopharmacol, 18, pp. 38-49.
145. Spina, E and Pisani, F and Perucca, E. (1996) Clinically significant pharmacokinetic drug interactions with carbamazepine Clin Pharmacokinet, 31, pp. 198-214. An update
146. Strömgren, L and Boller, S. (1985) Carbamazepine in treatment and prophylaxis of manic-depressive disorder Psychiatr Dev, 3, pp. 349-367.
147. Suppes, T and Baldessarini, R and Faedda, G and Tondo, L and Tohen, M. (1993) Discontinuation of maintenance treatment in bipolar disorder: risks and implications Harv Rev Psychiatry, 1, pp. 131-144.
148. Suppes, T and Phillips, K and Judd, C. (1994) Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: A report of three cases Biol Psychiatry, 36, pp. 338-340.
149. Suppes, T and Brown, E and McElroy, S and Keck, P and Nolen, W and Kupka, R and Frye, M and Denicoff, K and Altshuler, L and Leverich, G and Post, R. (1999a) Lamotrigine for the treatment of bipolar disorder: a clinical case series J Affect Disord, 53, pp. 95-98.
150. Suppes, T and Leverich, G and Keck, P and Nolen, W and Denicoff, K and Altshuler, L and McElroy, S and Rush, A and Kupka, R and Frye, M and Bickel, M and Post, R. (2001) The Stanley Foundation Bipolar Treatment Outcome Network, II, Demographics and illness characteristics of the first 261 patients J Affect Disord, 67, pp. 45-59.
151. Suppes, T and Dennehy, E and Swann, A and Bowden, C and Calabrese, J and Hirschfeld, R and Keck, P, Jr and Sachs, G and Crismon, M and Toprac, M and Shon, S. (2002) Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000 J Clin Psychiatry, 63, pp. 288-299.
152. Suppes, T and Webb, A and Paul, B and Carmody, T and Kraemer, H and Rush, A. (1999b) Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania Am J Psychiatry, 156, pp. 1164-1169.
153. Swoboda, E and Conca, A and Konig, P and Waanders, R and Hansen, M. (2001) Maintenance electroconvulsive therapy in affective and schizoaffective disorder Neuropsychobiology, 43, pp. 23-28.
154. Tohen, M and Baker, R and Altshuler, L and Zarate, C and Suppes, T and Ketter, T and Milton, D and Risser, R and Gilmore, J and Breier, A and Tollefson, G. (2002a) Olanzapine versus divalproex in the treatment of acute mania Am J Psychiatry, 159, pp. 1011-1017.
155. Tohen, M and Chengappa, K and Suppes, T. (2002b). Efficacy of olanzapine in combination with valproate or lithium for relapse prevention of bipolar disorder: An 18-month study.Presented at the American Psychiatric Association Annual Meeting PhiladelphiaPAMay18-23 2002. In [pp.].
156. Tohen, M and Marneros, A and Bowden, C and Calabrese, J and Greil, W and Koukopoulis, A and Belmaker, R and Jacobs, T and Robert, M and Baker, R and Williamson, D and Evans, A and Cassano, G. (2002c) Olanzapine versus lithium in relapse prevention in bipolar disorder: A randomized double-blind controlled 12-month clinical trial Bipolar Disord 4 Suppl 1, pp. 135.
157. Tohen, M and Ketter, T and Zarate, C and Suppes, T and Frye, M and Altshuler, L and Zajecka, J and Schuh, L and Risser, R and Brown, E and
158. Tohen, M and Bowden, C and Calabrese, J and Chou, J and Baker, R and Williamson, D and Evans, A. (2004) Olanzapine's efficacy for relapse prevention in bipolar disorder: A randomized double-blind controlled 12-month clinical trial World J Biol Psychiatry, 5, pp. 51.
159. Tondo, L and Baldessarini, R. (2000) Reduced suicide risk during lithium maintenance treatment J Clin Psychiatry, pp. 97-104. Suppl 9
160. Tondo, L and Baldessarini, R and Hennen, J and Floris, G. (1998) Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders Am J Psychiatry, 155, pp. 638-645.
161. Tran, P and Tollefson, G and Sanger, T and Lu, Y and Berg, P and Beasley, C. (1999) Olanzapine versus haloperidol in the treatment of schizoaffective disorder Br J Psychiatry, 174, pp. 15-22.
162. Tress, W and Haag, H. (1979) Vergleichende Erfahrungen mit der rezidivprophylaktischen Lithium-Langzeitmedikation bei schizoaffektiven Psychosen Nervenarzt, 50, pp. 524-526.
163. Vanelle, J and Loo, H and Galinowski, A and de Carvalho, W and Bourdel, M and Brochier, P and Bouvet, O and Brochier, T and Olie, J. (1994) Maintenance ECT in intractable manic-depressive disorders Convuls Ther, 10, pp. 195-205.
164. Vencovsky, E and Soucek, K and Kabes, J. (1984) Prophylactic effect of dipropylacetamide in patients with bipolar affective disorder. In Anticonvulsants in affective disorders. (pp. 66-67). Amsterdam: Excerpta Medica.
165. Vieta, E and Benabarre, A and Colom, F and Gasto, C and Nieto, E and Otero, A and Vallejo, J. (1997a) Suicidal behavior in bipolar I and bipolar II disorder J Nerv Ment Dis, 185, pp. 407-409.
166. Vieta, E and Gasto, C and Otero, A and Nieto, E and Vallejo, J. (1997b) Differential features between bipolar I and bipolar II disorder Compr Psychiatry, 38, pp. 98-101.
167. Vieta, E and Goikolea, J and Corbella, B and Benabarre, A and Reinares, M and Martinez, G and Fernandez, A and Colom, F and Martinez-Aran, A and Torrent, C. (2001) Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: Results from a 6-month, multicenter, open study J Clin Psychiatry, 62, pp. 818-825.
168. Vovin, R and Digilov, A and Skorik, A. (1984) Zh Nevropatol Psikhiatr Im S S Korsakova, 84, pp. 1226-1230. [Preventive treatment of affective psychoses with finlepsin]
169. Walden, J and Grunze, H. (2002). Prospective, randomised study on valproate, lithium, valproate + lithium and lamotrigine in Bipolar I rapid cycling patients. Proceedings SMRI research Center conference, Bethesda, MD, November 8 2002. In [pp.].
170. Walden, J and Hesslinger, B and van Calker, D and Berger, M. (1996) Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder Pharmacopsychiatry, 29, pp. 193-195.
171. Walden, J and Schaerer, L and Schlösser, S and Grunze, H. (2000) An open longitidinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilzation Bipolar disorders, 2, pp. 336-339.
172. Yatham, L. (2000) Efficacy and tolerability of risperidone as combination therapy in bipolar mania: Results from a randomised, double-blind study, (RIS-INT-46) Eur Neuropsychopharmacol, 10, pp. 250. Suppl 3
173. Zarate, C and Tohen, M. (2004) Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients Am J Psychiatry, 161, pp. 169-171.
174. Zarate, C and Tohen, M and Baldessarini, R. (1995a) Clozapine in severe mood disorders J Clin Psychiatry, 56, pp. 411-417.
175. Zarate, C and Tohen, M and Banov, M and Weiss, M and Cole, J. (1995b) Is clozapine a mood stabilizer? J Clin Psychiatry, 56, pp. 108-112.
176. Zarin, D and Pincus, H and McIntyre, J. (2002) APA Practice Guideline For The Treatment Of Patients With Bipolar Disorder. Electronic Citation http://www.psych.org/clin_res/pg_bipolar.cfm
177. Zis, A and Grof, P and Webster, M. (1980) The cyclicity of affective disorders and its modification by drugs Psychopharmacol, 16, pp. 47-49.